Axcella Stock Today


USD 2.33  0.01  0.43%   

Market Performance
11 of 100
Odds Of Distress
Over 77
Axcella Health is trading at 2.33 as of the 12th of August 2022, a -0.43 percent decrease since the beginning of the trading day. The stock's open price was 2.34. Axcella Health has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for Axcella Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of July 2022 and ending today, the 12th of August 2022. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
9th of May 2019
Health Care
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 38.92 M outstanding shares of which 81.32 K shares are presently shorted by private and institutional investors with about 1.51 trading days to cover. More on Axcella Health
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Axcella Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Axcella Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Axcella Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Axcella Health is way too risky over 90 days horizon
Axcella Health appears to be risky and price may revert if volatility continues
Axcella Health has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (68.48 M).
Axcella Health currently holds about 63.22 M in cash with (56.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Axcella Health has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from North American Morning Briefing Stock Futures -2- -
President CEOBill Hinshaw
Fama & French Classification
Average Analyst Recommendation
Analysts covering Axcella Health report their recommendations after researching Axcella Health's financial statements, talking to executives and customers, or listening in on Axcella Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Axcella Health. The Axcella consensus assessment is calculated by taking the average forecast from all of the analysts covering Axcella Health.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Axcella Health based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Axcella Health financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares31.1 M38.1 M
Significantly Down
Slightly volatile
Weighted Average Shares Diluted31.1 M38.1 M
Significantly Down
Slightly volatile
Total Assets75.8 M57.7 M
Significantly Up
Slightly volatile
Total Liabilities37.8 M35.7 M
Notably Up
Slightly volatile
Current Assets74.6 M56.6 M
Significantly Up
Slightly volatile
Current Liabilities9.8 M10.2 M
Sufficiently Down
Slightly volatile
Total Debt27 M25.1 M
Significantly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Axcella Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Axcella Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Axcella Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Axcella Health's financial leverage. It provides some insight into what part of Axcella Health's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Axcella Health's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Axcella Health deploys its capital and how much of that capital is borrowed.
Axcella Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 28.35 M in liabilities with Debt to Equity (D/E) ratio of 0.95, which is about average as compared to similar companies. Axcella Health has a current ratio of 4.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Axcella Health until it has trouble settling it off, either with new capital or with free cash flow. So, Axcella Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Axcella Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Axcella to invest in growth at high rates of return. When we think about Axcella Health's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(58.5 Million)
Axcella Health (AXLA) is traded on NASDAQ Exchange in USA. It is located in 840 Memorial Drive and employs 59 people. Axcella Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 96.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Axcella Health's market, we take the total number of its shares issued and multiply it by Axcella Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Axcella Health conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 38.92 M outstanding shares of which 81.32 K shares are presently shorted by private and institutional investors with about 1.51 trading days to cover. Axcella Health currently holds about 63.22 M in cash with (56.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Check Axcella Health Probability Of Bankruptcy
Axcella Health holds a total of thirty-eight million nine hundred twenty thousand outstanding shares. Over half of Axcella Health outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Axcella Health. Please watch out for any change in the institutional holdings of Axcella Health as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Axcella Ownership Details

Axcella Stock Price Odds Analysis

What are Axcella Health's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Axcella Health jumping above the current price in 90 days from now is about 15.07%. The Axcella Health probability density function shows the probability of Axcella Health stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3122. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Axcella Health will likely underperform. Additionally, the company has an alpha of 0.6426, implying that it can generate a 0.64 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 2.33HorizonTargetOdds Above 2.33
84.86%90 days
Based on a normal probability distribution, the odds of Axcella Health to move above the current price in 90 days from now is about 15.07 (This Axcella Health probability density function shows the probability of Axcella Stock to fall within a particular range of prices over 90 days) .

Axcella Health Historical Income Statement

Axcella Health Income Statement is one of the three primary financial statements used for reporting Axcella's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Axcella Health revenue and expense. Axcella Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
The current year Interest Expense is expected to grow to about 3.2 M, whereas Consolidated Income is forecasted to decline to (69.7 M). View More Fundamentals

Axcella Stock Against Markets

Picking the right benchmark for Axcella Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Axcella Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Axcella Health is critical whether you are bullish or bearish towards Axcella Health at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Axcella Health without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now


Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Invested in Axcella Health?

You need to understand the risk of investing before taking a position in Axcella Health. The danger of trading Axcella Health is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axcella Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axcella Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axcella Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Axcella Health information on this page should be used as a complementary analysis to other Axcella Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Axcella Stock analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
123.6 M
Return On Assets
Return On Equity
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.